Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
CELLPOINT

Cell Point (India) Share Price

 

 

Cell Point (India) live price: ₹16.45. It opened at ₹16 vs previous close ₹16; intraday high/low: ₹16/₹16. The 50 & 200 DMA stand at ₹15.84/₹17.52.

Cell Point (India) Performance

  • Today's Low
  • ₹16
  • Today's High
  • ₹16
  • 52 Week Low
  • ₹12
  • 52 Week High
  • ₹21
  • Open Price₹16
  • Previous Close₹16
  • Volume4,800
  • 50 DMA₹15.84
  • 100 DMA₹16.10
  • 200 DMA₹17.52

Cell Point (India) Chart

Investment Returns

  • Over 1 Month -3.8%
  • Over 3 Month + 7.17%
  • Over 6 Month -4.08%
  • Over 1 Year -7.58%

Smart Investing Starts Here Start SIP with Cell Point (India) for Steady Growth!

Invest Now

Cell Point (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 13.6
  • PEG Ratio
  • -
  • Market Cap Cr
  • 31
  • P/B Ratio
  • 0.4
  • Average True Range
  • 0.74
  • EPS
  • 0.2
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.22
  • RSI
  • 54.82
  • MFI
  • 70.13

Cell Point (India) Financials

Cell Point (India) Technicals

EMA & SMA

Current Price
₹16.45
+ 0.15 (0.92%)
pointer
  • Bearish Moving Average 4
  • Bullish Moving Average 12
  • 20 Day
  • ₹16.10
  • 50 Day
  • ₹15.84
  • 100 Day
  • ₹16.10
  • 200 Day
  • ₹17.52

Resistance and Support

16.45 Pivot Speed
  • R3 16.45
  • R2 16.45
  • R1 16.45
  • S1 16.45
  • S2 16.45
  • S3 16.45

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Cell Point (India) Ltd has an operating revenue of Rs. 822.88 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 1% needs improvement, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 56 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 88 indicates it belongs to a poor industry group of Telecom-Consumer Prods and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Cell Point (India) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-27 Audited Results
2025-12-08 Others inter alia, To consider seeking Shareholders approval by way of postal ballot for appointment Mrs. Sailaja Penmetsa (DIN: 11354469), Non-executive Independent Director. Final Dividend of Re. 0.25/- (Twenty Five paisa) per equity share of Rs. 10/- each
2025-11-12 Quarterly Results
2025-09-02 Others To consider & approve 1. Draft Report from Board of directors for the financial year ended 31/03/2025. 2. Approve Date, Time, Venue, Notice of 12th AGM. 3. Other business matters. Final Dividend of Re. 0.25/- (Twenty Five paisa) per equity share of Rs. 10/- each
2025-05-29 Audited Results

Cell Point (India) Shareholding Pattern

73.06%
24.18%
2.76%

Cell Point (India) FAQs

Cell Point (India) share price is ₹16 As on 24 May, 2026 | 22:27

The Market Cap of Cell Point (India) is ₹30.7 Cr As on 24 May, 2026 | 22:27

The P/E ratio of Cell Point (India) is 13.6 As on 24 May, 2026 | 22:27

The PB ratio of Cell Point (India) is 0.4 As on 24 May, 2026 | 22:27

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23